SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-057727
Filing Date
2021-04-29
Accepted
2021-04-29 17:00:00
Documents
14
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212613-2_def14a.htm DEF 14A 5005957
2 GRAPHIC lg_anipharma-black.jpg GRAPHIC 12835
3 GRAPHIC lg_houlihanlokey-4c.jpg GRAPHIC 21237
4 GRAPHIC sg_houlihanlkey-bw.jpg GRAPHIC 11181
5 GRAPHIC sg_nikhillalwani-bw.jpg GRAPHIC 21470
6 GRAPHIC sg_ramassociates-bw.jpg GRAPHIC 7695
7 GRAPHIC sg_stephen-carey.jpg GRAPHIC 9281
8 GRAPHIC tm212613d1-eq_formula1bwlr.jpg GRAPHIC 6034
9 GRAPHIC tm212613d1-eq_formula2bwlr.jpg GRAPHIC 11713
10 GRAPHIC tm212613d1-icon_wedo4clr.jpg GRAPHIC 1147
11 GRAPHIC tm212613d1-icon_wedont4clr.jpg GRAPHIC 1219
12 GRAPHIC tm212613d1-pc_ceo4c.jpg GRAPHIC 50910
13 GRAPHIC tm212613d2-proxy_1anibw.jpg GRAPHIC 500551
14 GRAPHIC tm212613d2-proxy_2anibw.jpg GRAPHIC 465716
  Complete submission text file 0001104659-21-057727.txt   6536425
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 21871748
SIC: 2834 Pharmaceutical Preparations